BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20111957)

  • 21. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha.
    Lee SK; Huang H; Lee SW; Kim KH; Kim KK; Kim HM; Lee ZH; Kim HH
    Exp Cell Res; 2004 Aug; 298(2):359-68. PubMed ID: 15265685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
    Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
    Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
    Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.
    Yoshimoto T; Takeda K; Tanaka T; Ohkusu K; Kashiwamura S; Okamura H; Akira S; Nakanishi K
    J Immunol; 1998 Oct; 161(7):3400-7. PubMed ID: 9759857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locally administered T cells from mice immunized with lipopolysaccharide (LPS) accelerate LPS-induced bone resorption.
    Ozaki Y; Ukai T; Yamaguchi M; Yokoyama M; Haro ER; Yoshimoto M; Kaneko T; Yoshinaga M; Nakamura H; Shiraishi C; Hara Y
    Bone; 2009 Jun; 44(6):1169-76. PubMed ID: 19437611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives.
    Ruggiero V; Piovesan P; Fabrizi C; Lauro GM; Campo S; Albertoni C; Nucera E; Carminati P; Ghirardi O
    Shock; 2004 Jan; 21(1):77-85. PubMed ID: 14676688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways.
    Nakao A; Fukushima H; Kajiya H; Ozeki S; Okabe K
    Biochem Biophys Res Commun; 2007 Jun; 357(4):945-50. PubMed ID: 17467668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
    Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
    J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compressive mechanical force augments osteoclastogenesis by bone marrow macrophages through activation of c-Fms-mediated signaling.
    Cho ES; Lee KS; Son YO; Jang YS; Lee SY; Kwak SY; Yang YM; Park SM; Lee JC
    J Cell Biochem; 2010 Dec; 111(5):1260-9. PubMed ID: 20803546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTLA-4 directly inhibits osteoclast formation.
    Axmann R; Herman S; Zaiss M; Franz S; Polzer K; Zwerina J; Herrmann M; Smolen J; Schett G
    Ann Rheum Dis; 2008 Nov; 67(11):1603-9. PubMed ID: 18203760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoclastogenesis-related antigen, a novel molecule on mouse stromal cells, regulates osteoclastogenesis.
    Arai S; Amizuka N; Azuma Y; Takeshita S; Kudo A
    J Bone Miner Res; 2003 Apr; 18(4):686-95. PubMed ID: 12674329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitonin gene-related peptide indirectly inhibits IL-7 responses in pre-B cells by induction of IL-6 and TNF-alpha in bone marrow.
    Fernandez S; Knopf MA; Shankar G; McGillis JP
    Cell Immunol; 2003 Dec; 226(2):67-77. PubMed ID: 14962494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro.
    Pfeilschifter J; Chenu C; Bird A; Mundy GR; Roodman GD
    J Bone Miner Res; 1989 Feb; 4(1):113-8. PubMed ID: 2785743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
    Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
    Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.